PROVIDING PATIENT EDUCATION SERVICES

Brand Owner (click to sort) Address Description
ATTAIN Dicerna Pharmaceuticals, Inc. 75 Hayden Avenue Lexington MA 02421 Providing patient education services, namely, conducting classes in the field of healthcare and medicine;Providing medical and health information services; providing health care services;
DARETODREAM PROJECT THE LEUKEMIA & LYMPHOMA SOCIETY, INC. 3 International Drive, Suite 200 Rye Brook NY 10573 Providing patient education services in the field of cancer;DARE TO DREAM PROJECT;Accepting and administering monetary charitable contributions in the field of cancer;Promoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy;Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support in the field of cancer;Providing medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of cancer; providing information in the field of cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of cancer;Medical research services in the field of cancer; conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research in the field of cancer; consulting services for others, namely, helping others design, plan, implement, and manage clinical trials in the field of cancer;
LEUKEMIA & LYMPHOMA SOCIETY DARETODREAM PROJECT THE LEUKEMIA & LYMPHOMA SOCIETY, INC. 3 International Drive, Suite 200 Rye Brook NY 10573 Providing patient education services in the field of cancer;The mark consists of a red drop design to the left of the wording LEUKEMIA & LYMPHOMA SOCIETY in grey, followed by a grey vertical line; to the right of the vertical line is the wording DARETODREAM PROJECT with DARE and DREAM in red and TO and PROJECT in grey, and a red star design in the upper right.;LEUKEMIA AND LYMPHOMA SOCIETY DARE TO DREAM PROJECT;Accepting and administering monetary charitable contributions in the field of cancer;The color(s) red and grey is/are claimed as a feature of the mark.;Promoting the interests of cancer patients and medical professionals in the field of cancer by means of public advocacy; promoting public awareness of cancer by means of public advocacy;Providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support in the field of cancer;Providing medical counseling and information about medical terms and clinical trials to patients, families, and healthcare providers in the field of cancer; providing information in the field of cancer treatment; providing nutritional consultations to patients, families, and caregivers in the field of cancer;Medical research services in the field of cancer; conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research in the field of cancer; consulting services for others, namely, helping others design, plan, implement, and manage clinical trials in the field of cancer;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. An integrated home health system includes a television-based patient station, a first provider station for providing telemedicine or other healthcare services to a patient located at the patient station, a second provider station for providing caregiver services to the patient, a third provider station for providing emergency response services to the patient and a system management station coupled together by a data network. In addition to various management operations performed on behalf of the integrated home health system, the system management station is further configured to provide various home health services to the patient located at the patient station, either alone, or in conjunction with one or more of the first, second and/or third provider stations.